|
Lipid and lipoprotein metabolism
Citations 481-490 of 549 total displayed.
|
Past content
(since Jan 1999):
|
- Clinical Investigations and Reports
Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid Plaques : Implications for Plaque Stabilization
- Milita Crisby, Gunilla Nordin-Fredriksson, Prediman K. Shah, Juliana Yano, Jenny Zhu, and Jan Nilsson
Circulation 2001;103:926-933
[Abstract]
[Full text]
- Basic Science Reports
Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits
- Yoshihiro Fukumoto, Peter Libby, Elena Rabkin, Christopher C. Hill, Makoto Enomoto, Yasuhiko Hirouchi, Masashi Shiomi, and Masanori Aikawa
Circulation 2001;103:993-999
[Abstract]
[Full text]
- AHA Conference Proceedings
Summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health : Conference Summary From the Nutrition Committee of the American Heart Association
- Penny Kris-Etherton, Stephen R. Daniels, Robert H. Eckel, Marguerite Engler, Barbara V. Howard, Ronald M. Krauss, Alice H. Lichtenstein, Frank Sacks, Sachiko St. Jeor, Meir Stampfer, Robert H. Eckel, Scott M. Grundy, Lawrence J. Appel, Tim Byers, Hannia Campos, Greg Cooney, Margo A. Denke, Barbara V. Howard, Eileen Kennedy, Ronald M. Krauss, Penny Kris-Etherton, Alice H. Lichtenstein, Peter Marckmann, Thomas A. Pearson, Gabriele Riccardi, Lawrence L. Rudel, Mike Rudrum, Frank Sacks, Daniel T. Stein, Russell P. Tracy, Virginia Ursin, Robert A. Vogel, Peter L. Zock, Terry L. Bazzarre, and Julie Clark
Circulation 2001;103:1034-1039
[Full text]
- Clinical Investigations and Reports
Common Hepatic Lipase Gene Promoter Variant Determines Clinical Response to Intensive Lipid-Lowering Treatment
- Alberto Zambon, Samir S. Deeb, B. Greg Brown, John E. Hokanson, and John D. Brunzell
Circulation 2001;103:792-798
[Abstract]
[Full text]
- Clinical Investigations and Reports
Common Genetic Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease
- Susanne M. Clee, Aeilko H. Zwinderman, James C. Engert, Karin Y. Zwarts, Henri O. F. Molhuizen, Kirsten Roomp, J. Wouter Jukema, Michel van Wijland, Marjel van Dam, Thomas J. Hudson, Angela Brooks-Wilson, Jacques Genest, Jr, John J. P. Kastelein, and Michael R. Hayden
Circulation 2001;0:13r-20r
[Abstract]
[Full text]
- Clinical Investigations and Reports
PPAR Agonists Inhibit Tissue Factor Expression in Human Monocytes and Macrophages
- Bernadette P. Neve, Delphine Corseaux, Giulia Chinetti, Christophe Zawadzki, Jean-Charles Fruchart, Patrick Duriez, Bart Staels, and Brigitte Jude
Circulation 2001;103:207-212
[Abstract]
[Full text]
- Clinical Investigations and Reports
PPAR Activators Inhibit Tissue Factor Expression and Activity in Human Monocytes
- Nikolaus Marx, Nigel Mackman, Uwe Schönbeck, Nurcan Yilmaz, Vinzenz Hombach, Peter Libby, and Jorge Plutzky
Circulation 2001;103:213-219
[Abstract]
[Full text]
- Editorials
Cracking Down on Caveolin: Role of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Modulating Edothelial Cell Nitric Oxide Production
- Michael E. Davis and David G. Harrison
Circulation 2001;103:2-4
[Full text]
- Basic Science Reports
Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance
- Olivier Feron, Chantal Dessy, Jean-Pierre Desager, and J.-L. Balligand
Circulation 2001;103:113-118
[Abstract]
[Full text]
- Clinical Investigations and Reports
Simvastatin Improves Disturbed Endothelial Barrier Function
- Geerten P. van Nieuw Amerongen, Mario A. Vermeer, Pascale Nègre-Aminou, Jan Lankelma, Jef J. Emeis, and Victor W. M. van Hinsbergh
Circulation 2000;102:2803-2809
[Abstract]
[Full text]
|
|
